These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 3064527

  • 1. [Use of plasmapheresis in therapy of systemic lupus erythematosus: a controlled study].
    Zielinski C, Müller C, Smolen J.
    Acta Med Austriaca; 1988; 15(5):155-8. PubMed ID: 3064527
    [Abstract] [Full Text] [Related]

  • 2. Plasmapheresis in five dogs with systemic immune-mediated disease.
    Matus RE, Gordon BR, Leifer CE, Saal S, Hurvitz AI.
    J Am Vet Med Assoc; 1985 Sep 15; 187(6):595-9. PubMed ID: 4086366
    [Abstract] [Full Text] [Related]

  • 3. Evidence for a therapeutic effect of plasmapheresis in patients with systemic lupus erythematosus.
    Jones JV, Cumming RH, Bacon PA, Evers J, Fraser ID, Bothamley J, Tribe CR, Davis P, Hughes GR.
    Q J Med; 1979 Oct 15; 48(192):555-76. PubMed ID: 317156
    [Abstract] [Full Text] [Related]

  • 4. [Plasma exchange therapy in children and adolescents with systemic lupus erythematosus (SLE)].
    Pistor K, Neudorf U.
    Monatsschr Kinderheilkd; 1987 Jan 15; 135(1):47-50. PubMed ID: 3494196
    [Abstract] [Full Text] [Related]

  • 5. [Value of plasma exchange in neurologic complications of acute disseminated lupus erythematosus in children].
    Couillault G, Gouyon JB, Chalopin JM, Rifle G, Nivelon JL.
    Arch Fr Pediatr; 1985 Jan 15; 42(1):41-3. PubMed ID: 3872647
    [Abstract] [Full Text] [Related]

  • 6. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
    Euler HH, Guillevin L.
    Ann Med Interne (Paris); 1994 Jan 15; 145(5):296-302. PubMed ID: 7985935
    [Abstract] [Full Text] [Related]

  • 7. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
    Demin AA, Sentiakova TN, Smirnov VV, Demina LM, Mamin IV.
    Ter Arkh; 1996 Jan 15; 68(5):27-30. PubMed ID: 9082593
    [Abstract] [Full Text] [Related]

  • 8. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA.
    Rheumatology (Oxford); 2005 Dec 15; 44(12):1542-5. PubMed ID: 16188950
    [Abstract] [Full Text] [Related]

  • 9. Oral contraceptive therapy and systemic lupus erythematosus.
    Travers RL, Hughes GR.
    J Rheumatol; 1978 Dec 15; 5(4):448-51. PubMed ID: 310887
    [Abstract] [Full Text] [Related]

  • 10. [Intensified therapy of severe lupus erythematosus].
    Euler HH, Schröder JO, Gutschmidt HJ, Harten P, Stueber F, Zeuner RA, Löffler H.
    Dtsch Med Wochenschr; 1991 Jul 12; 116(28-29):1081-8. PubMed ID: 2065594
    [Abstract] [Full Text] [Related]

  • 11. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M, Chorzelski T, Daszyński J, Gaczkowski A, Jabłońska S, Beutner EH.
    Arch Immunol Ther Exp (Warsz); 1981 Jul 12; 29(6):769-72. PubMed ID: 6983871
    [Abstract] [Full Text] [Related]

  • 12. Severe infections in plasmapheresis-treated systemic lupus erythematosus.
    Aringer M, Smolen JS, Graninger WB.
    Arthritis Rheum; 1998 Mar 12; 41(3):414-20. PubMed ID: 9506568
    [Abstract] [Full Text] [Related]

  • 13. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.
    Marks SD, Patey S, Brogan PA, Hasson N, Pilkington C, Woo P, Tullus K.
    Arthritis Rheum; 2005 Oct 12; 52(10):3168-74. PubMed ID: 16200620
    [Abstract] [Full Text] [Related]

  • 14. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
    Nguyen CP, Cao VV, Fehér J, Gergely P.
    Acta Med Hung; 1988 Oct 12; 45(2):145-59. PubMed ID: 3266790
    [Abstract] [Full Text] [Related]

  • 15. Plasmapheresis combined with corticosteroids and cyclophosphamide in uncontrolled active systemic lupus erythematosus.
    Schildermans F, Dequeker J, Van de Putte I.
    J Rheumatol; 1979 Oct 12; 6(6):687-90. PubMed ID: 529252
    [Abstract] [Full Text] [Related]

  • 16. [Therapy of severe systemic lupus erythematosus].
    Schmidt RE, Witte T, Deicher H, Neumann KH, Schaumann D, Koch KM.
    Dtsch Med Wochenschr; 1991 Dec 06; 116(49):1891-3. PubMed ID: 1743102
    [No Abstract] [Full Text] [Related]

  • 17. [Lupus erythematosus and plasma exchange. A case report].
    Schildermans F, Walravens M, Dequeker J, van de Putte I.
    Acta Rhumatol Belg; 1978 Dec 06; 2(3-4):127-31. PubMed ID: 757115
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
    Francioni C, Fioravanti A, Gelli R, Megale F, Marcolongo R.
    Recenti Prog Med; 1993 Oct 06; 84(10):679-86. PubMed ID: 8235034
    [Abstract] [Full Text] [Related]

  • 19. Cryopheresis in the treatment of systemic lupus erythematosus.
    Stewart DW, Ballard JO, Schoolwerth AC.
    Trans Am Soc Artif Intern Organs; 1984 Oct 06; 30():222-6. PubMed ID: 6335931
    [No Abstract] [Full Text] [Related]

  • 20. [Status of plasmapheresis and cyclosporin A in the treatment of systemic lupus erythematosus].
    Graf N, Bambauer R, Jost W, Schäfer M.
    Monatsschr Kinderheilkd; 1990 Jul 06; 138(7):395-8. PubMed ID: 2398909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.